Placement Completed
Imugene placement (March 2026)
A$20m raised
Announced 11 Mar 2026 · ASX: IMU · A$0.18 cash per share
Advisers
Imugene
Issuer
- Legal adviser
Lead managers
- Joint lead manager
- Bookrunner
- Issuer
- Imugene
- Issuer based in
- Australia
- Completed
- 19 Mar 2026
- Sector
- Biotech
- Tags
- Biotech, Oncology
Similar deals
- Chimeric Therapeutics placement (May 2025) May 2025 · A$6.6m · Biotech
- Liminatus Pharma equity raising Feb 2026 · A$5.7m · Biotech
- Scancell Holdings placement Jul 2026 · A$77.2m · Biotech
- Silexion Therapeutics Corp equity raising A$3.6m · Biotech
- Remix Therapeutics placement Jun 2026 · A$143m · Biotech
Sources
- 11 Mar 2026 $20M placement and SPP, convertible notes amended ASX
- 19 Mar 2026 Application for quotation of securities - IMU ASX
- 24 Mar 2026 $20M Capital Raising and Convertible Notes Issue mccullough.com.au


